Literature DB >> 12114690

Failure of Partial Hypophysectomy as Definitive Treatment in Cushing's Disease Owing to Nodular Corticotrope Hyperplasia: Report of Four Cases.

Luiz R. Salgado, Berenice B. Mendonca, Jayme Goldman, Mauro Semer, Mirta Knoepfelmacher, Ana M. Tsanaclis, Bernardo L. Wajchenberg, Bernardo Liberman.   

Abstract

Nodular corticotrope hyperplasia is a rare pathology causing Cushing's syndrome owing to a primary pituitary disease or ectopic CRH production. In this study, we evaluated the laboratory and pathological findings and results of transsphenoidal pituitary surgery in four patients with Cushing's disease. Dynamic tests of pituitary-adrenal function (dexamethasone suppression, metyrapone, CRH, and DDAVP tests) were done before and after transsphenoidal pituitary surgery. Plasma and total urinary cortisol, serum 11-deoxycortisol, and plasma ACTH were determined by RIA. Hormonal dynamic tests and radiologic studies were compatible with a pituitary ACTH source. The transsphenoidal surgery revealed the presence of corticotrope hyperplasia confirmed by immunoperoxidase stain and a preserved reticulum framework in the removed pituitary tissue of these four patients. The pituitary surgery led to a short period of improvement in two of the patients (1 and 4), a 3-yr remission in one patient (patient 2), and no improvement in one (patient 3). We conclude that although our patients appear to have inadequate suppression with high-dose dexamethasone, there is no way to diagnose this pathology presurgically, and that total hypophysectomy, bilateral adrenalectomy, and irradiation are the only alternatives for definitive treatment. A CRH-secreting ectopic tumor could not be found in our patients either before or after surgery in the follow-up period.

Entities:  

Year:  1995        PMID: 12114690     DOI: 10.1007/bf02914989

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  29 in total

1.  Cushing's syndrome due to ectopic production of corticotropin-releasing factor.

Authors:  J L Belsky; B Cuello; L W Swanson; D M Simmons; R M Jarrett; F Braza
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

2.  Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion.

Authors:  D E Schteingart; R V Lloyd; H Akil; W F Chandler; G Ibarra-Perez; S G Rosen; R Ogletree
Journal:  J Clin Endocrinol Metab       Date:  1986-09       Impact factor: 5.958

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  The corticotropin releasing hormone gene is expressed in human placenta.

Authors:  M Grino; G P Chrousos; A N Margioris
Journal:  Biochem Biophys Res Commun       Date:  1987-11-13       Impact factor: 3.575

Review 5.  The Cushing syndrome: an update on diagnostic tests.

Authors:  T B Kaye; L Crapo
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

6.  Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome?

Authors:  C W Burke; C B Adams; M M Esiri; C Morris; J S Bevan
Journal:  Clin Endocrinol (Oxf)       Date:  1990-10       Impact factor: 3.478

7.  Characterization of human corticotrophin-releasing hormone and pro-opiomelanocortin-related peptides in a thymic carcinoid tumour responsible for Cushing's syndrome.

Authors:  M C Raux Demay; M F Proeschel; Y de Keyzer; X Bertagna; J P Luton; F Girard
Journal:  Clin Endocrinol (Oxf)       Date:  1988-12       Impact factor: 3.478

8.  Failure of clinical remission after transsphenoidal removal of a microadenoma in a patient with Cushing's disease: multiple hyperplastic and adenomatous cell nets in surrounding pituitary tissue.

Authors:  S W Lamberts; S Z Stefanko; S A de Lange; H Fermin; J C van der Vijver; R F Weber; F H de Jong
Journal:  J Clin Endocrinol Metab       Date:  1980-04       Impact factor: 5.958

9.  Cushing's disease associated with an intrasellar gangliocytoma producing corticotrophin-releasing factor.

Authors:  S L Asa; K Kovacs; G T Tindall; D L Barrow; E Horvath; P Vecsei
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

10.  Pituitary pathology in Cushing's disease.

Authors:  W Saeger; F Geisler; D K Lüdecke
Journal:  Pathol Res Pract       Date:  1988-09       Impact factor: 3.250

View more
  1 in total

Review 1.  [Space occupying processes of the sellar region with emphasis on tumor-like lesions].

Authors:  W Saeger
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.